Home > Company Profiles > Izvarino Pharma Corporate functions : Moscow, Russia Year of incorporation : 2007 Number of employees : 410 Production Footprint : Izvarino and Nanopharma (Russia) Izvarino Pharma provides a professional and competent approach to female healthcare Established in 2007, Izvarino Pharma is a Russian pharmaceutical company focused on the production, marketing and distribution of high-demand medical products in the Russian market. Today its portfolio includes almost 50 products. The company operates two plants: Izvarino Pharma in Moscow and Nanopharma Development in Kazan. Izvarino also develops innovative technologies for reduced toxicity and improved bio-availability of active pharmaceutical ingredients Strengths Izvarino specialises in manufacturing drugs for the treatment of obesity, HIV, cancer, and organ and tissue transplantation and other socially significant diseases. The company’s competitive advantage lies in its expertise in the development of formulations for solid dosage and the latest technological solutions for tablets and capsules. Izvarino’s focus on obesity is not only pharmaceutical. Driven by the conviction that it can best help patients across their entire lifespan, the company offers an educational program led by endocrinologists. This interactive platform allows patients to safely plan and monitor their tailored response to the challenges they face. Another of Izvarino’s major strengths lies in the very fact that it is based in Russia. This means that a SEVER company produces essential medication in Russia – especially in the fight against HIV and cancer – and significantly adds to SEVER’s geographical reach. With Izvarino’s two facilities already approved for Good Manufacturing Practice (GMP), this advantage cannot be underestimated: establishing a new company in Russia is fraught with political and bureaucratic difficulties. Business type: B2B Pharma company – branded products Reimbursable products for gov’t designated public health needs Non-branded generics (INNs to chains) Core treatment areas Cancer Central nervous system Infections (HIV) Gynecology Endocrinology Cardiovascular system Capabilities: Commercialization (contracts with institutional buyers) Development Manufacturing Commercial Technology Tablets and capsules Vials, prefilled syringes, cartridges Visit website Company commercial footprint Corporate functions Commercial footprint Manufacturing footprint Other company profiles Address SEVER Life Sciences BV Siriusdreef 41 2132 WT Hoofddorp The Netherlands Contact Phone +41 58 301 0102 E-mail info@severlifesciences.com © SEVER Life Sciences. All rights reserved.